Skip to main content
SpringerLink
Log in

Cytogenetic Markers in Selected Gynecological Malignancies

  • Chapter
Human Cytogenetic Cancer Markers

Part of the book series: Contemporary Biomedicine ((CB,volume 13))

Abstract

The gynecological tissues of a mature female, because of their reproductive function, contain examples of the most immature as well as mature cell types. Thus, representation of all three germ layers may be found in tumors originating from these tissues. Moreover, new tissue types appear in the course of pregnancy that may also develop aberrantly and give rise to neoplasms. Some of these tumors illustrate mechanisms of tumorigenesis that differ from those operating in other solid tumors and that appear uniquely related to early development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heim S, Mitelman F: Cancer Cytogenetics, 2nd edition. New York: Wiley-Liss, 1995.

    Google Scholar 

  2. Taylor RR, Teneriello MG, Nash JD, Park RC, Birrer MJ: The molecular genetics of gynecologic malignancies. Oncology 8:63–70, 1994.

    PubMed  CAS  Google Scholar 

  3. Sreekantaiah C, Chaganti RSK: Cytogenetic aberrations in solid tumors. In: Kaplan BJ, Dale KS (eds.), The Cytogenetic Symposia 1994. Burbank, CA: The Association of Cytogenetic Technologies, pp. 1–11, 1994.

    Google Scholar 

  4. Rodriquez E, Sreekantaiah C, Chaganti RSK: Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398–3406, 1994.

    Google Scholar 

  5. Vanni R, Dal Cin P, Marras S, Moerman P, Andria M, Valdes E, Deprest J, Van Den Berghe H: Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet 68:32–33, 1993.

    Article  PubMed  CAS  Google Scholar 

  6. Heim S, Nibert M, Vanni R, Floderus U-M, Mandahl N, Liedgren S, Lecca U, Mitelman F: A specific translocation, t(12; 14)(q 14–15;q23–24), characterizes a subgroup of uterine leiomyomas. Cancer Genet Cytogenet 32:13–17, 1988.

    Article  PubMed  CAS  Google Scholar 

  7. Hu J, Surti U: Subgroups of uterine leiomyomas based on cytogenetic analysis. Hum Pathol 22:1009–1016, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Turc Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA: Cytogenetic studies of adipose tissue tumors. I. A benign lipoma with reciprocal translocation t(3;12)(q28;ql4). Cancer Genet Cytogenet 23:283–289, 1986.

    Article  PubMed  CAS  Google Scholar 

  9. Zang ZK: Cytological and cytogenetical study on human meningioma. Cancer Genet Cytogenet 6:249–274, 1982.

    Article  PubMed  CAS  Google Scholar 

  10. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57–65, 1995.

    Article  PubMed  CAS  Google Scholar 

  11. Schoenberg Fejzo M, Ashar H, Tkachenko A, Fletcher JA, Weremowicz S, Yoong S-J, Krauter KS, Kucherlapati R, Chada K, Morton CC: HMGI-C: an architectural factor at 12ql4–15 involved in frequent chromosomal rearrangement in benign tumors. Am J Hum Genet 57:A4, 1995.

    Google Scholar 

  12. Ishwad CS, Ferrell RE, Davare J, Meloni A, Sandberg AA, Surti U: Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosom Cancer 14:51–55, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Bar-Jensen E, Frederiksen H, Sandberg AA, Mitelman F: Recurrent chromosome aberrations in abdominal smooth muscle tumors. Cancer Genet Cytogenet 62:43–46, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Fotiou SK, Tserkezoglou AJ, Mahera H, Konstandinidou AE, Agnantis NJ, Pandis N, Bardi G: Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of uterus. Eur J Gynecol Oncol 13:340–345, 1992.

    CAS  Google Scholar 

  15. Fletcher JA, Morton CC, Pavelka K, Lage JM: Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res 50:4092–4097, 1990.

    PubMed  CAS  Google Scholar 

  16. Nilbert M, Jin Y, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F: Chromosome rearrangements in two uterine sarcomas. Cancer Genet Cytogenet 44:27–35, 1990.

    Article  PubMed  CAS  Google Scholar 

  17. Boghosian L, Dal Cin P, Turc-Carel C, Rao U, Karakousis C, Sait SJ, Sandberg AA: Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet 43:39–49, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Dal Cin P, Boghosian L, Sandberg AA: t(10; 17) as the sole chromosome change in a uterine leiomyosarcoma. Cancer Genet Cytogenet 32:263–266, 1988.

    Article  Google Scholar 

  19. Havel G, Dahlenfors R, Wedell B, Mark J: Similar chromosomal evolution in a uterine stromomyosarcoma and in one of two leiomyomas from the same patient. APMIS 94:143–146, 1989.

    Article  Google Scholar 

  20. Laxman R, Currie JL, Kurman RJ, Dudzinski M, Griffin CA: Cytogenetic profile of uterine sarcomas. Cancer 71:1283–1288, 1993.

    Article  PubMed  CAS  Google Scholar 

  21. Kajii T, Ohama K: Androgenetic origins of hydatidiform mole. Nature 268:633,634, 1977.

    Google Scholar 

  22. Wake N, Takagi N, Sasaki M: Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst 60:51, 1978.

    PubMed  CAS  Google Scholar 

  23. Surti U, Szulman AE, O’Brien S: Complete (classic) hydatidiform mole with 46,XY karyotype of paternal origin. Hum Genet 51:153–155, 1979.

    Article  PubMed  CAS  Google Scholar 

  24. Surti U, Szulman AE: Cytogenetics, morphology and clinical outcome of classical and partial hydatidiform moles. Am J Hum Genet 29:104A, 1977.

    Google Scholar 

  25. Szulman AE, Surti U: The syndromes of hydatidiform moles: I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 131:665–671, 1978.

    PubMed  CAS  Google Scholar 

  26. Szulman AE, Surti U: The syndromes of hydatidiform moles: II. Morphologic evolution. Am J Obstet Gynecol 132:20–27, 1978.

    PubMed  CAS  Google Scholar 

  27. Jacobs PA, Angell RR, Buchanan IM, Hassold TJ: The origin of human triploids. Ann Hum Genet 42:49–57, 1978.

    Article  PubMed  CAS  Google Scholar 

  28. Szulman, AE, Surti U: Clinico-pathological profile of partial hydatidiform mole. Obstet Gynecol 59:597–602, 1982.

    PubMed  CAS  Google Scholar 

  29. Doshi N, Surti U, Szulman AE: Morphologic anomalies in triploid liveborn fetuses. Hum Pathol 14:716–723, 1983.

    Article  PubMed  CAS  Google Scholar 

  30. Jacobs PA, Wilson CM, Sprenkle JA, et al.: Mechanism of origin of complete hydatidiform moles. Nature 286:714–716, 1980.

    Article  PubMed  CAS  Google Scholar 

  31. Lawler SD, Povey S, Fisher RA, et al.: Genetic studies on hydatidiform moles II. The origin of complete moles. Ann Hum Genet 46:209, 1982.

    Article  PubMed  CAS  Google Scholar 

  32. Lawler SD, Fisher RA, Pickthall VJ, et al.: Genetic studies on hydatidiform moles I. The origin of partial moles. Cancer Genet Cytogenet 5:309–320, 1982.

    Article  PubMed  CAS  Google Scholar 

  33. Ohama K, Kajii T, Okamoto E, et al.: Dispermic origin of XY hydatidiform moles. Nature 292:551–552, 1981.

    Article  PubMed  CAS  Google Scholar 

  34. Surti U, Szulman AE, O’Brien S: Dispermic origin and clinical outcome of three complete hydatidiform moles with 46,XY karyotype. Am J Obstet Gynecol 144:84–87, 1982.

    PubMed  CAS  Google Scholar 

  35. Surti U, Szulman AE, Wagner K, Leppert M, White R, O’Brien S: Two tetraploid partial hydatidiform moles with triple paternal contribution and 92,XXXY karyotype. Hum Genet 72:15–21, 1986.

    Article  PubMed  CAS  Google Scholar 

  36. Vejerslev LO, Fisher RA, Surti U, Wake N: Hydatidiform mole: cytogeneti-cally unusual cases: implications for the present classification. Am J Obstet Gynecol 157:180–184, 1987.

    PubMed  CAS  Google Scholar 

  37. Wallace DC, Surti U, Adams C, Szulman AE: Complete moles have paternal chromosomes but maternal mitochondrial DNA. Hum Genet 61:145–147, 1982.

    Article  PubMed  CAS  Google Scholar 

  38. Wake N, Tanaka K, Chapman V, Metsui S, Sandberg AA: Chromosomes and cellular origin of choriocarcinoma. Cancer Res 41:3137–3143, 1981.

    PubMed  CAS  Google Scholar 

  39. Sheppard DM, Fisher RA, Lawler SD: Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet 16:251–258, 1985.

    Article  PubMed  CAS  Google Scholar 

  40. Habibian R, Surti U: Cytogenetics of trophoblasts from complete hydatidiform moles. Cancer Genet Cytogenet 29:271–287, 1987.

    Article  PubMed  CAS  Google Scholar 

  41. Surti U, Habibian R: Chromosomal rearrangement in choriocarcinoma cell lines. Cancer Genet Cytogenet 38:229–240, 1989.

    Article  PubMed  CAS  Google Scholar 

  42. Bettio D, Giardino D, Rizzi N, Simoni G: Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet 68:149–151, 1993.

    Article  PubMed  CAS  Google Scholar 

  43. Surti U, Juda S, Krishnan S, Alavizadeh S, Leger W: Characterization of chromosomes 7 and 12 abnormalities in gestational choriocarcinoma. Am J Hum Genet 51:4, 1992

    Google Scholar 

  44. Fisher RA, Paradinas FJ, Newland ES, Boxer GM: Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 65:355–358, 1992.

    Article  PubMed  CAS  Google Scholar 

  45. Arima T, Imamura T, Amada S, Tsuneyoshi M, Wake N: Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 73:95–102, 1994.

    Article  PubMed  CAS  Google Scholar 

  46. Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, Kimura T, Tokugawa Y, Kanai T, Saji F: Loss of imprinting in choriocarcinoma. Nature Genetics 9:109, 110, 1995.

    Article  PubMed  CAS  Google Scholar 

  47. Damjanov I: The pathology of human teratomas. In: Damjanov I, Knowles BB, Solter D (eds.), The Human Teratoma: Experimental and Clinical Biology. Clifton, NJ: Humana Press, pp. 23–54, 1983.

    Google Scholar 

  48. Surti U, Hoffner L, Chakravarti A, Ferrell R: Genetics of human ovarian teratomas: I. Cytogenetic analysis and mechanism of origin. Am J Human Genet 47:635–643, 1990.

    CAS  Google Scholar 

  49. Hoffner L, Deka R, Chakravarti A, Surti U: Cytogenetics and origin of pediatric germ cell tumors. Cancer Genet Cytogenet 74:54–58, 1994.

    Article  PubMed  CAS  Google Scholar 

  50. Climie ARW, Health LP: Malignant degeneration of benign cystic teratomas of the ovary. Review of the literature and report of a chondrosarcoma and carcinoid tumor. Cancer 22:824–832, 1968.

    Article  PubMed  CAS  Google Scholar 

  51. Tobon H, Surti U, Naus GJ, Hoffner L, Hemphill RW: Squamous cell carcinoma in situ arising in an ovarian mature cystic teratoma: report of one case with histopathologic, cytogenetic and flow cytometric DNA content analysis. Arch Pathol Lab Med 115:172–174, 1991.

    PubMed  CAS  Google Scholar 

  52. Peterson WF, Prevost EC, Edmunds FT, Huntly JM, Morris FK: Benign cystic teratomas of the ovary: a clinicostatistical study of 1007 cases with a review of the literature. Am J Obstet Gynecol 70:368–382, 1995.

    Google Scholar 

  53. Linder D, Power J: Further evidence of post-meiotic origin of teratomas in the human female. Ann Hum Genet 34:21–30, 1970.

    Article  PubMed  CAS  Google Scholar 

  54. Patil S, Kaiser-McCaw B, Hecht F, Linder D, Lovrien E: Human benign ovarian teratomas: chromosomal and electrophoretic enzyme studies. Birth Defects Orig Article Ser 14:297–301, 1978.

    CAS  Google Scholar 

  55. Linder D, McCaw BK, Hecht F: Parthenogenic origin of benign ovarian teratomas. N Engl J Med 292:63–66, 1975.

    Article  PubMed  CAS  Google Scholar 

  56. Carritt B, Parrington JM, Welch HM, Povey S: Diverse origins of multiple ovarian teratomas in a single individual. Proc Natl Acad Sci USA 79: 7400–7404, 1982.

    Article  PubMed  CAS  Google Scholar 

  57. Parrington J, West L, Povey S: The origin of ovarian teratomas. J Med Genet 21:4–12, 1984.

    Article  PubMed  CAS  Google Scholar 

  58. Ohama K: Androgenesis and parthenogenesis in humans. In: Vogel F, Springer K (eds.), Human Genetics. Berlin, Germany: Springer, pp. 245–249, 1987.

    Google Scholar 

  59. Deka R, Chakravarti A, Surti U, Hauselman E, Reefer J, Majumder PP, Ferrell RE: Genetics and biology of human ovarian teratomas: II. Molecular analysis of origin of non-disjunction and gene-centromere mapping of chromosome 1 markers. Am J Hum Genet 47:644–655, 1990.

    PubMed  CAS  Google Scholar 

  60. Chakravarti A, Majumder PP, Slaugenhaupt SA, Deka R, Warren AC, Surti U, Ferrell RE, et al.: Gene-centromere mapping and the study of non-disjunction in autosomal trisomies and ovarian teratomas. In: Hassold TJ, Epstein CJ (eds.), Molecular and Cytogenetic Studies of Non-Disjunction. New York: Liss, pp. 45–79, 1989.

    Google Scholar 

  61. Warren AC, Chakravarti A, Wong C, Slaugenhaupt SA, Halloran SL, Watkins PC, Metaxotous C, Antonarakis SE: Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science 237:652–654, 1987.

    Article  PubMed  CAS  Google Scholar 

  62. Dahl N, Gustavson K-H, Rune C, Gustavsson I, Pettersson U: Benign ovarian teratomas-an analysis of their cellular origin. Cancer Genet Cytogenet 46:115–123, 1990.

    Article  PubMed  CAS  Google Scholar 

  63. Arias-Bernal L: Chromosomes of a malignant ovarian teratoma. Am J Obstet Gynecol 100:785–789, 1968.

    PubMed  CAS  Google Scholar 

  64. Serr DM, Padeh B, Mashiach S, Shaki R: Chromosomal studies in tumors of embryonic origin. Obstet Gynecol 33:324–332, 1969.

    PubMed  CAS  Google Scholar 

  65. Atkin NB, Baker MC, Robinson R, Gage SE: Chromosome studies in 14 near-diploid carcinomas of the ovary. Eur J Cancer 10:143–146, 1974.

    Article  Google Scholar 

  66. Kusyk CJ, Terpening EL, Edwards CL, Wharton JT, Copeland LJ: Karyotype analysis of four solid gynecologic tumors. Gynecol Oncol 14:324–338, 1982.

    Article  PubMed  CAS  Google Scholar 

  67. Ihara T, Ohama K, Satoh M, Fujii T, Nomura K, Fujiwara A: A histologic grade and karyotype of immature teratoma of the ovary. Cancer 54:2944–2988, 1984.

    Article  Google Scholar 

  68. Yang-Feng TL, Katz SN, Cacanjiu ML, Schwartz PE: Cytogenetic analysis of ependymoma and teratoma of the ovary. Cancer Genet Cytogenet 35:83–89, 1988.

    Article  PubMed  CAS  Google Scholar 

  69. King ME, DiGiovanni LM, Yung J-F, Clarke-Pearson DL: Immature teratoma of the ovary Grade 3 with karyotype analysis. Int J Gyn Pathol 9:178–184, 1990.

    Article  CAS  Google Scholar 

  70. Gibas Z, Talerman A: Cytogenetic analysis of a metastatic immature teratoma of the ovary: Abstract No. B22. Fourth International Workshop on Chromosomes in Solid Tumors. Tucson, Arizona, 1991.

    Google Scholar 

  71. Jenkyn DJ, McCartney AJ: A chromosome study of three ovarian tumors. Cancer Genet Cytogenet 26:327–337, 1987.

    Article  PubMed  CAS  Google Scholar 

  72. Hoffner L, Shen-Schwarz S, Deka R, Chakravarti A, Surti U: Genetics and biology of human ovarian teratomas. III. Cytogenetics and origin of malignant ovarian germ cell tumors. Cancer Genet Cytogenet 62:58–65, 1992.

    Article  PubMed  CAS  Google Scholar 

  73. Oosterhuis JW, Looijenga LHJ, van Kessel AG, de Jong B: A cytogenetic classification of germ cell tumors and its biological relevance. Eur Urol 23:6–8, 1993.

    PubMed  Google Scholar 

  74. Atkin NB, Baker MC: Abnormal chromosomes including small metacentric in 14 human ovarian cancers. Cancer Genet Cytogenet 26:355–361, 1987.

    Article  PubMed  CAS  Google Scholar 

  75. Speleman F, DePotter C, Dal Cin P, Mangelschots K, Ingelaere H, Laurey G, Benoit Y, Leroy J, Van den Berghe H: I(12p) in a malignant ovarian tumor. Cancer Genet Cytogenet 45:49–53, 1990.

    Article  PubMed  CAS  Google Scholar 

  76. Speleman F, Laureys G, Benoit Y, Cuvelier C, Suikerbuijk R, DeJong B: I(12p) in a near-diploid mature ovarian teratoma. Cancer Genet Cytogenet 60:216–218, 1992.

    Article  PubMed  CAS  Google Scholar 

  77. Ohama K, Normua K, Okamoto E, Fukuda Y, Ihara T, Fujiwara A: Origin of immature teratoma of the ovary. Am J Obstet Gynecol 152:869–890, 1985.

    Google Scholar 

  78. Barton SC, Surani MAH, Norris ML: Role of paternal and maternal genomes in mouse development. Nature 311:374–376, 1984.

    Article  PubMed  CAS  Google Scholar 

  79. Driscoll DJ, Waters MF, Williams CA, Zori RT, Glenn CC, Avidano KM, Nicholls RD: A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes. Genomics 13:917–924, 1992.

    Article  PubMed  CAS  Google Scholar 

  80. Mowery-Rushton PA, Driscoll DJ, Nicholls RD, Locker J, Surti U: DNA methylation patterns in human tissues of uniparental origin using a zinc-finger gene (ZNF127) from the Angelman/Prader-Willi region. Am J Med Genet 61:140–146, 1996.

    Article  PubMed  CAS  Google Scholar 

  81. Feinberg AP, Rainier S, DeBaun MR: Genomic imprinting, DNA methylation, and cancer. J Natl Cancer Inst Monogr 17:21–26, 1995.

    PubMed  Google Scholar 

  82. Wutz A, Smrzka OW, Barlow DP, Neumann B: Genomic imprinting: the parental connection. Appl Cytogenet 21:145–152, 1995.

    Google Scholar 

Download references

Authors
  1. Urvashi Surti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lori Hoffner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Sandra R. Wolman MD

  2. Department of Pathology, Albany Medical College, Albany, NY, USA

    Stewart Sell MD

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Humana Press Inc.

About this chapter

Cite this chapter

Surti, U., Hoffner, L. (1997). Cytogenetic Markers in Selected Gynecological Malignancies. In: Wolman, S.R., Sell, S. (eds) Human Cytogenetic Cancer Markers. Contemporary Biomedicine, vol 13. Humana Press. https://doi.org/10.1007/978-1-4612-3952-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3952-9_9

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-8437-6

  • Online ISBN: 978-1-4612-3952-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation